Higher Prevalence of Extended Spectrum β-Lactamase Producing Uropathogenic Escherichia coli Among Patients with Diabetes from a Tertiary Care Hospital of Kathmandu, Nepal.


Journal

The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507

Informations de publication

Date de publication:
23 08 2021
Historique:
received: 17 06 2021
accepted: 06 07 2021
pubmed: 24 8 2021
medline: 22 2 2022
entrez: 23 8 2021
Statut: epublish

Résumé

This study aimed to determine the occurrence of antibiotic resistance genes for β-lactamases; blaTEM and blaCTX-M in uropathogenic Escherichia coli isolates from urinary tract infection (UTI) suspected diabetic and nondiabetic patients. A hospital-based cross-sectional study was conducted in Kathmandu Model Hospital, Kathmandu, in association with the Department of Microbiology, GoldenGate International College, Kathmandu, Nepal, from June to December 2018. A total of 1,267 nonduplicate midstream urine specimens were obtained and processed immediately for isolation of uropathogens. The isolates were subjected to antibiotic susceptibility testing and extended spectrum β-lactamase (ESBL) confirmation. In addition, blaTEM and blaCTX-M genes were detected using specific primers. The overall prevalence of UTI was 17.2% (218/1,267), of which patients with diabetes were significantly more infected; 32.3% (31/96) as compared with nonpatients with diabetes, 15.9% (187/1,171). A total of 221 bacterial isolates were obtained from 218 culture-positive specimens in which E. coli was the most predominant; 67.9% (150/221). Forty-four percent (66/150) of the total E. coli was multidrug resistant and 37.3% (56/150) were ESBL producers. Among 56 isolates, 92.3% (12/13) were from patients with diabetes, and 83.0% (44/53) were from nondiabetics. Furthermore, 84.9% of the screened ESBL producers were confirmed to possess either single or both of blaTEM and blaCTX-M genes. The blaTEM and blaCTX-M genes were detected in 53.6% and 87.5% of the phenotypically ESBL confirmed E. coli, respectively. Higher rates of ESBL producing uropathogenic E. coli are associated among patients with diabetes causing an alarming situation for disease management. However, second-line drugs with broad antimicrobial properties are still found to be effective drugs for multidrug resistance strains.

Identifiants

pubmed: 34424860
doi: 10.4269/ajtmh.21-0691
pii: tpmd210691
pmc: PMC8592212
doi:
pii:

Substances chimiques

Anti-Infective Agents 0
beta-Lactamases EC 3.5.2.6

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1347-1355

Auteurs

Tulsi Nayaju (T)

Department of Microbiology, GoldenGate International College, Kathmandu, Nepal.

Milan Kumar Upreti (MK)

Department of Microbiology, GoldenGate International College, Kathmandu, Nepal.

Alina Ghimire (A)

Department of Microbiology, GoldenGate International College, Kathmandu, Nepal.

Basudha Shrestha (B)

Kathmandu Model Hospital, Kathmandu, Nepal.

Basanta Maharjan (B)

Kathmandu Model Hospital, Kathmandu, Nepal.

Rajesh Dhoj Joshi (RD)

Kathmandu Model Hospital, Kathmandu, Nepal.

Binod Lekhak (B)

Central Department of Microbiology, Tribhuvan University, Kirtipur, Kathmandu, Nepal.

Upendra Thapa Shrestha (U)

Central Department of Microbiology, Tribhuvan University, Kirtipur, Kathmandu, Nepal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH